Aster DM Healthcare reports 18% Q4 FY26 revenue growth; merger with QCIL advances
Aster DM Quality Care · Healthcare Services
Key highlights
- Q4 FY26 standalone revenue rose 18% YoY to ₹1,182 crore; Operating EBITDA (ex-Kasargod) increased 31% to ₹253 crore with 21.7% margin
- Combined proforma Q4 FY26 revenue with QCIL grew 18% to ₹2,361 crore; Operating EBITDA up 25% to ₹517 crore with 21.9% margin
- Merger with Quality Care India Ltd secured 96.68% shareholder approval; expected completion by Q1 FY27 pending regulatory approvals
Why it's rated notable: the year-on-year change is 45% (20% to 50%)
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Aster DM Quality Care
- Acquisition / mergerNotable· Adverse for the businessAster DM Quality Care converts INR 102.46 Cr subsidiary loan, to end DMERF agreements
- Acquisition / mergerNotableBCP Asia II Topco IV Pte. Ltd. acquires 29.71% stake in Aster DM Quality Care Limited
- Fundraise / allotmentNotableAster DM Quality Care Limited approves allotment of equity shares post-amalgamation
- Acquisition / mergerNotableAster DM Healthcare completes merger with Quality Care India Limited, starts operations
- Acquisition / mergerNotableAster DM Healthcare's amalgamation with Quality Care India effective 1 July 2026
Other acquisition / merger filings this fortnight
- IndiGrid Infrastructure Trust Q2 FY27 Earnings Conference Call Transcript Released
- Cubical Financial Services Ltd announces promoter reclassification post open offer
- Novus Loyalty Limited approves acquisition of AutoPe Payment Solutions via share swap
- Shish Industries Limited files Composite Scheme of Amalgamation proposal
- Jubilant Ingrevia Limited updates on acquisition of 40% stake in Zettaone Technologies
- NHC Foods approves quarter results, 99.98% Sachmaas Foods investment, two appointments
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- 3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.